Information Document

Pursuant to Regulation (EU) 2017/1129 of 14 June 2017 (Article 1.4(θ) regarding the exemption from the obligation to publish a prospectus for the offering of the New Shares, in relation to the admission to trading of 250,000 new ordinary registered shares of “European Innovation Solutions S.A.” under the distinctive title “E.In.S. S.A.” (formerly “Euroconsultants S.A.”), for the third (3rd) period of the Programme (from 27.9.2025 to 26.9.2026 and in respect of rights granted to beneficiaries by the Board of Directors’ resolution dated 9.3.2026), in implementation of the Company’s Stock Option Plan, which was established by the Board of Directors’ resolution dated 27.09.2023 pursuant to the authorization granted by the Annual Ordinary General Meeting dated 09.06.2023, as amended and currently in force by virtue of the unanimous resolution of the First Adjourned Annual General Meeting of 24.6.2025 (regarding the adjustment of the exercise price), and duly published in the General Commercial Registry (G.E.MI.).

Thessaloniki, 24 April 2026

This Information Document, prepared pursuant to Regulation (EU) 2017/1129 of 14 June 2017 (Article 1.4(θ), relates to the offering of 250,000 new ordinary registered shares of the company “European Innovation Solutions S.A.” under the distinctive title “E.In.S. S.A.” (formerly “Euroconsultants S.A.”) (hereinafter the “Company”), which informs the investing public, in accordance with Article 1(4)(i) of Regulation (EU) 2017/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as in force, regarding the offering of the total of 250,000 stock option rights of the third (3rd) period of the Programme (from 27.9.2025 to 26.9.2026) for the acquisition of 250,000 ordinary registered shares with voting rights.

More specifically, with respect to the Stock Option Plan in force (currently in its third implementation period), the Company announces that on 20.6.2023, the resolution dated 09.06.2023 of the Annual Ordinary General Meeting of the Shareholders was registered with the General Commercial Registry (G.E.MI.) under Registration Code No. 3656002 by the Companies Directorate, Listed Companies Department of the Ministry of Development and Investments. By virtue of said resolution, the Board of Directors was authorized to establish a Stock Option Plan for the granting of stock options for the acquisition of newly issued shares, in accordance with Article 113 of Law 4548/2018, to be granted to executives, employees of the Company, as well as to persons providing services to the Company on a regular basis.

The purpose of the Programme is both to reward their active contribution to achieving the Company’s strategic objectives and to align their performance with the future performance of the Company and the Group as a whole. For the satisfaction of stock option rights, the Company proceeds to an increase of its share capital through the issuance of new shares in accordance with Article 113 of Law 4548/2018 and the resolution of the Annual General Meeting dated 9.6.2023, which was adopted unanimously with a quorum of 72.45% on the relevant agenda item.

The total duration of the Programme is three (3) years, commencing on 27.9.2023 and ending on 26.9.2026. This total duration is divided into three (3) separate “Annual Periods”:The First Period: from 27.9.2023 to 26.9.2024, the Second Period: from 27.9.2024 to 26.9.2025 and  the Third Period: from 27.9.2025 to 26.9.2026 .

The maximum total number of rights that may be granted during the Programme is up to 750,000 rights corresponding to 750,000 new ordinary registered shares of the Company, to be admitted to trading on Euronext Athens, representing 5.056% of the then paid-up share capital (i.e. below the 10% threshold set by Article 113(2) of Law 4548/2018). The Board of Directors resolves within each Annual Period on the beneficiaries and the number of rights allocated, with a maximum of 250,000 rights per Annual Period.

For the third (3rd) period, pursuant to the authorization of the General Meeting of 9.6.2023, the Board of Directors resolved on 9.3.2026 to allocate and grant the total of 250,000 stock option rights to ten (10) beneficiaries and set 9.3.2026 as the grant date. The granted rights vested for exercise as of 10.3.2026.

The exercise price per right (each corresponding to one new ordinary registered share) was set at €0.10, equal to the nominal value of the share, as determined by the resolution of the Annual General Meeting dated 9.6.2023, as amended by the unanimous resolution of the First Adjourned Annual General Meeting of 24.6.2025.

Accordingly, on 9.3.2026, 250,000 stock option rights were granted for the acquisition of 250,000 new shares, and ten (10) Registered Share Option Certificates were issued to the beneficiaries. On 10.3.2026, all beneficiaries exercised their rights in full, resulting in the exercise of 250,000 rights for the acquisition of 250,000 shares.

According to the Balance Certificate of OPTIMA BANK dated 13.3.2026, during the period from 10.3.2026 to 12.3.2026, the beneficiaries paid in cash a total amount of €25,000 into the Company’s designated account for the purposes of the capital increase.

On 16.3.2026, the Board of Directors resolved to increase the Company’s share capital by €25,000 through cash contribution and the issuance of 250,000 new shares with a nominal value and issue price of €0.10 each. On 24.3.2026, the Board certified the payment of the share capital increase.

On 2.4.2026, the capital increase and its certification were registered with the General Commercial Registry (G.E.MI.) under protocol numbers 4056168/02.04.2026 and 4056217/02.04.2026 respectively.

Following the above increase, the Company’s share capital amounts to €1,558,348.00, fully paid, divided into 15,583,480 ordinary registered shares with a nominal value of €0.10 each.

The New Shares will be of the same class as those already listed on the Main Market of Euronext Athens. The Company will follow the applicable procedures for their admission to trading in accordance with the Euronext Athens Rulebook and relevant Board decisions.

The starting trading price will be determined in accordance with the applicable rules of Euronext Athens and Decision No. 26 of its Board of Directors. The New Shares will be registered in the records of the Hellenic Central Securities Depository (ATHEXCSD) and credited to the beneficiaries’ accounts in the Dematerialised Securities System (DSS).

The Company will inform the investing public of the exact date of admission to trading.

Pursuant to Article 1(4)(i) of Regulation (EU) 2017/1129, no prospectus is required for this offering, as this document contains information on the number, nature, and reasons for the distribution of the securities.

The Company’s Shareholder Services Department is responsible for the preparation of this document and the accuracy of its contents (info@eins.com.gr, tel. +30 2310804000). The document is available in hard copy at the Company’s offices (21 Antonis Tritsis Street, Pylaia, Thessaloniki) and electronically at: https://www.eins.gr/el/investors